Join the Breast Cancer - Adjuvant group to help and get support from people like you.
Breast Cancer - Adjuvant News (Page 4)
Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
FRIDAY, Dec. 20, 2024 – For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety levels two to four hours after ingestion, according...
Some Breast Cancer Patients May Not Need Post-Op Chest Wall Radiation
WEDNESDAY, Dec. 18, 2024 – Radiation therapy for breast cancer comes with a host of side effects, including conditions as serious as heart problems and pneumonia. Now, a new study says some breast...
Breast Cancer Risk Increased With Weight Gain After Age 35 Years
WEDNESDAY, Dec. 18, 2024 – The risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recently published in Cancer Biology & Medicine. Katherine De...
San Antonio Breast Cancer Symposium, Dec. 10 to 13
The annual San Antonio Breast Cancer Symposium was held from Dec. 10 to 13 in San Antonio. Attendees included medical oncologists, radiation oncologists, researchers, and other health care p...
Breast Reconstruction Rates Stable After Increase From 2005 to 2012
FRIDAY, Dec. 13, 2024 – Breast reconstruction (BR) rates increased from 2005 to 2012, then stabilized from 2013 to 2017, according to a study published online in the December issue of Plastic and...
SABCS: Adding Camrelizumab to Neoadjuvant Chemo Beneficial in TNBC
FRIDAY, Dec. 13, 2024 – The addition of camrelizumab to neoadjuvant chemotherapy improves pathological complete response for patients with early or locally advanced triple-negative breast cancer,...
SABCS: Risk-Reducing Surgery Improves Outcomes in Young Breast Cancer Patients With BRCA Mutations
MONDAY, Dec. 16, 2024 – Risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO) are both associated with significant improvements in outcomes among young BRCA carriers with breast cancer,...
SABCS: Chest Wall Irradiation Does Not Impact Survival in Breast Cancer
MONDAY, Dec. 16, 2024 – For patients with intermediate-risk breast cancer, chest wall irradiation (CWI) after mastectomy does not influence 10-year overall survival, according to a study presented...
Study Supports Tamoxifen for DCIS Early Breast Cancers
MONDAY, Dec. 16, 2024 – The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study...
Breast, Ovary Removal Can Lengthen Lives of Women With Breast Cancer Genes
FRIDAY, Dec. 13, 2024 – It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from...
Newer Drug Imlunestrant Could Be Advance Against Tough-to-Treat Breast Cancers
FRIDAY, Dec. 13, 2024 – An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows. The drug,...
SABCS: Omission of Axillary Staging Noninferior for Node-Negative Breast Cancer
FRIDAY, Dec. 13, 2024 – Omission of surgical axillary staging is noninferior to sentinel-lymph-node biopsy for patients with clinically node-negative, T1 or T2 invasive breast cancer, according to a...
SABCS: Active Monitoring Noninferior to Guideline Care for Ductal Carcinoma in Situ
FRIDAY, Dec. 13, 2024 – For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) that involves surgery with or without adjuvant...
'Watch and Wait' May Equal Active Treatment for Early DCIS Breast Cancers, Studies Find
FRIDAY, Dec. 13, 2024 – A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer. According to two new studies presented Thursday at the San Ant...
Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
THURSDAY, Dec. 12, 2024 – Low-dose oral minoxidil (LDOM) is effective for alopecia in patients with breast cancer, according to a letter to the editor published online Dec. 3 in the Journal of the...